# Ground Truth Medical Form (GTMF)

## Patient Information

- **Subject ID**: 7995
- **Admission ID**: 119166
- **Row ID**: 14971
- **Profile Type**: FULL

## Demographics

- **Age**: 74
- **Sex**: F
- **Date of Birth**: 2056-04-09
- **Ethnicity**: WHITE
- **Marital Status**: SINGLE
- **Religion**: OTHER
- **Insurance**: Medicare
- **Admission Type**: EMERGENCY
- **Admission Date**: 2130-07-28 18:35:00
- **Discharge Date**: 2130-08-02 13:37:00

## Chief Complaint

fall and right hip pain

## Symptoms

- **fall**
- **right hip pain** | onset: after falling
- **cold right foot** | onset: prior to right femoral bypass surgery
- **anemia** | duration: longstanding
- **acute renal failure** | duration: resolved
- **asymptomatic urinary tract infection** | severity: asymptomatic

## Medical History

chronic obstructive pulmonary disease, glaucoma, rheumatoid arthritis, osteoarthritis, hypertension, osteopenia, peripheral vascular disease, status post right femoral bypass, deep venous thrombosis (6 years ago), cellulitis (recent, treated with Keflex)

## Current Medications

- **Atrovent**
- **Lasix**
- **Colace**
- **Plavix**
- **Metoprolol**
- **Prednisone**
- **Eye drops for glaucoma**
- **Lisinopril** | dosage: 7.5 | frequency: q.d.
- **Protonix**
- **Nicotine patch**
- **Subcutaneous heparin**
- **Keflex** | frequency: day 8 of 10 | purpose: cellulitis
- **Lovenox** | purpose: anticoagulation
- **Coumadin** | purpose: anticoagulation

## Discharge Medications

- **Atrovent** | dosage: two puffs | frequency: q.i.d.
- **Colace** | dosage: 100 mg | frequency: PO b.i.d.
- **Senna** | dosage: one to two tablets | frequency: PO t.i.d.
- **Coumadin** | dosage: 2.5 mg | frequency: PO q.d.
- **Metoprolol** | dosage: 12.5 mg | frequency: PO b.i.d.
- **Prednisone** | dosage: 2.5 mg | frequency: PO q.d.
- **Latanoprost** | dosage: one drop OD | frequency: q.h.s.
- **Betaxolol HCL 0.25%** | dosage: one drop to both eyes | frequency: q.a.m.
- **Lisinopril** | dosage: 7.5 mg | frequency: PO q.d.
- **Protonix** | dosage: 40 mg | frequency: PO q.d.
- **Nicotine patch** | dosage: 14 mg | frequency: transdermally q.d.
- **Lovenox** | dosage: 30 mg | frequency: subcutaneously b.i.d.
- **Calcitonin** | dosage: 200 IU | frequency: intranasal q.d.
- **Calcium carbonate** | dosage: 500 mg | frequency: PO q.d.
- **OxyContin** | dosage: 60 mg | frequency: PO b.i.d.
- **Oxycodone** | dosage: 5 mg to 10 | frequency: PO q.4h.to 6h.p.r.n.pain
- **Ciprofloxacin** | dosage: 250 mg | frequency: PO b.i.d. to be finished, last day [**2130-8-7**]
- **Plavix** | dosage: 75 mg | frequency: PO q.d.

## Diagnoses

- chronic obstructive pulmonary disease
- glaucoma
- rheumatoid arthritis
- osteoarthritis
- hypertension
- osteopenia
- peripheral vascular disease
- status post right femoral bypass
- deep venous thrombosis (history, 6 years ago)
- cellulitis (recent, treated with Keflex)
- **right hip fracture** | notes: nondisplaced intertrochanteric femur fracture
- **anemia** | notes: longstanding history
- **acute renal failure** | notes: resolved with IV hydration and holding of Lasix
- **asymptomatic urinary tract infection** | notes: diagnosed by urinalysis, urine culture pending
- **demineralized bones** | notes: spinal demineralization on imaging
- **emphysematous changes** | notes: on chest x-ray
- **gallstones** | notes: positive on imaging
- **hepatic cysts** | notes: on imaging
- **calcified aorta** | notes: on imaging
- **enlarged right thyroid** | notes: on imaging
- **left ventricular hypertrophy** | notes: unchanged from previous EKG

## Treatment Options

### right femoral bypass surgery

**Details**: performed for peripheral vascular disease

### rehabilitation

**Details**: after bypass surgery

### open reduction and internal fixation surgery

**Details**: performed by Department of Orthopedics for right hip fracture

### blood transfusion

**Details**: two units of packed red blood cells
**Treatment**: for anemia

### IV hydration

**Details**: for acute renal failure

### Staple removal

**Details**: Staples from hip surgery to be removed on [**2130-8-12**]

### Anticoagulation management

**Details**: Lovenox to be continued until INR reaches 1.5-2.0 on Coumadin, then Lovenox can be discontinued. Coumadin to be continued until follow-up with orthopedic surgeon.

**Medications**:
- Lovenox (not provided)
- Coumadin (not provided)

### INR monitoring

**Details**: Check INR every day
